CSPC Pharmaceutical Group (HK:1093) has released an update.
CSPC Pharmaceutical Group Limited has recently executed an on-market share purchase for its share award scheme, acquiring 5,590,000 shares at an average price of HK$6.779 per share, amounting to a total consideration of approximately HK$37,893,000. This purchase represents about 0.047% of the total shares in issue, with the shares being held in trust for the scheme’s selected participants. The company’s board retains discretion over further share awards and purchases under the scheme.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
